Abbott US diabetes device sales up 27% amid largely positive Q1
Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to kickstart the year.
Business & Regulation
EU Health Data Space strikes a chord in EU harmonisation plans
FDA tags Becton, Dickinson and Company infusion software recall as Class I
Philips losses intensify amid demand drop in China and recall fallout
Medtronic stock down 5% as surgical unit offsets ablation and diabetes growth
Trump’s tariffs could strain medicine supply and drive drug costs
DACH region an “attractive place” to conduct clinical trials despite strict EU laws
MHRA puts technology in the spotlight in 2024/25 business plan
